Analyst Coverage

Firm Analyst Bank Hapoalim Yaron Freidman Barclays Doug Tsao BOFA Merrill Lynch Gregg Gilbert Buckingham Research David G. Buck Canaccord Genuity Randall Stanicky Clal Finance Batucha Jonathan Kreizman Cowen And Company Ken Cacciatore Credit Agricole Securities Kim Vukhac Credit Suisse - North America Michael Faerm CRT Capital Group Tim Chiang Dash Investment House Richard Gussow Deutsche Bank Research David M. Steinberg Exane BNP Paribas Florent Cespedes Excellence Nessuah Gilad Alper First Global Stockbroking Ltd. Kavita Thomas Gabelli & Company Kevin Kedra Goldman Sachs & Co. Jami Rubin Guggenheim Securities Louise Chen Harel Finance Steven Tepper Jefferies & Co. Corey  Davis JPMorgan Chris Schott Leader Capital Markets Sabina Podval Leerink Swann, LLC Jason Gerberry Miller Tabak & Co., LLC Les Funtleyder Morgan Stanley David Risinger Morningstar, Inc. Michael Waterhouse Needham & Company Elliot Wilbur Oppenheimer & Co. Christopher Holterhoff Piper Jaffray David Amsellem Poalim Sahar Yoav Burgan RBC Capital Markets Shibani Malhotra Sanford C. Bernstein & Co., LLC Aaron R Gal Standard & Poors Herman Saftlas Suntrust Robinson Humphrey Frank H. Pinkerton Susquehanna Financial Gary Nachman The Royal Bank of Scotland Savant Ahmed UBS (US) Marc Goodman Wall Street Strategies Carlos Guillen Wells Fargo Securities, LLC Michael Tong

Teva Pharmaceutical Industries Ltd is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Teva Pharmaceutical Industries Ltd's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Teva Pharmaceutical Industries Ltd or its management. Teva Pharmaceutical Industries Ltd does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.